3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Uterine Cervical Neoplasms
7
Uterine Cervical Dysplasia
6
Uterine Neoplasms
1
Uterine Diseases
1
Uterine Cervical Diseases
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Squamous Intraepithelial Lesions
1
Precancerous Conditions
1
Papillomavirus Infections
1
Neoplasms by Site
1
Neoplasms
1
Genital Neoplasms, Female
1
Genital Diseases, Female
1
Genital Diseases
1
Female Urogenital Diseases and Pregnancy Complications
1
Acquired Immunodeficiency Syndrome
1
Interventions
fludarabine
4
aldesleukin
4
Cyclophosphamide
4
pembrolizumab
3
niraparib
2
Riluzole
2
olaparib
1
motexafin gadolinium
1
lenvatinib
1
anlotinib
1
Watchful Waiting
1
Transurethral Resection of Prostate
1
Specimen Handling
1
Remote Patient Monitoring
1
Pregnancy Tests
1
Pemetrexed
1
Paclitaxel
1
Ocoxin
1
Loperamide
1
Imagery, Psychotherapy
1
Human Papillomavirus DNA Tests
1
Genetic Testing
1
Fulvestrant
1
Filgrastim
1
Fecal Microbiota Transplantation
1
Educational Status
1
Drug Therapy
1
Diffusion
1
Colposcopy
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Urogenital Neoplasms
×
Acetic Acid
×
Gynecologic
×
Clear all
NCT06815939
2026-01-29
OPTICS
DL Analytics
Phase NA
Recruiting
10,000 enrolled